Skip to main content
Working in Trudell Med Scientific

Clinical Evidence

Scientific information and resources to help you support your patients.

Image
Woman embracing elderly woman with AeroChamber graphic

Always prescribe a spacer with an MDI

When prescribing a metered dose inhaler, remember to include an AEROCHAMBER* brand of chambers for both children and adults. AEROCHAMBER* VHC is proven to deliver inhaler medication better than the inhaler alone.

Learn More

Image
Two women hike with backpacks.

Help your Bronchiectasis Patients Clear their Way to Better Health

The AEROBIKA* OPEP device is clinically proven to help patients clear their airways1

1) Svenningsen S, et al. Academic Radiology. 2017;24(1):4-12.

Learn More

Image
AeroChamber2Go with icons on the right

Deliver Inhaled Medication On-the-Go - NEW

The AEROCHAMBER2GO* Chamber is a compact, 2-in-1 chamber and protective case for the delivery of inhaler medication while on-the-go. Compact. Protected. Better delivery1,2

Learn More

Scientific & Performance Evidence

See the latest studies, research and related information.

Product Resources

View our product videos and download our how-to-use instructions and counseling materials.

Educational Webinars

Learn more from experts in respiratory medicine about how to help your patients manage their diseases.

Speak to a Representative

Contact us to find how we can help you and your patients.

Connect with Trudell Medical International

Get access to free patient resources including samples and demonstration kits, invitations to exclusive respiratory webinars, updates on the latest respiratory research and more.

Our Innovative Products

Featured Clinical Studies

A Comparison, Using Functional Respiratory Imaging (FRI), of Adult Airway Deposition Profiles from a Pressurized Metered Dose Inhaler with Valved Holding Chamber ( pMDI /VHC) and Two Dry Powder Inhalers (DPI)

AEROCHAMBER PLUS* FLOW-VU* Chamber

Greater Lung Deposition with AEROCHAMBER* VHC + MDI

Metered dose inhalers are an ideal delivery system for many respiratory patients. When combined with a spacer, they offer a number of advantages over dry powder inhaler devices.

View the Study

Bar graph showing 31% reduction

AEROBIKA* OPEP Device

Patients using the AEROBIKA* OPEP device had a 31% reduction in COPD/chronic bronchitis-related readmission within 30 days of the index hospitalization

A Retrospective Cohort Study Comparing the Impact of Two Oscillating Positive Expiratory Pressure (OPEP) Devices in Patients with Chronic Obstructive Pulmonary Disease (COPD) or Chronic Bronchitis on Hospital Readmissions at 30 Days and 12 Months

View the Study